Sugi Predict

Sugi Predict / Compounds / SCHEMBL233484

SCHEMBL233484

SCHEMBL233484

CCC(CC)OC(=O)CC(=O)OC(CC)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ SI P14410 1/20 0.43
▸ MGAM2 Q2M2H8 1/20 0.43
▸ CTSK P43235 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ LMNA P02545 3/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ RECQL P46063 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TSHR P16473 2/20 0.35
▸ PRKCA P17252 1/20 0.33
▸ PRKCE Q02156 1/20 0.33
▸ PRKCQ Q04759 1/20 0.33
▸ PRKCD Q05655 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ FAAH O00519 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7321395 0.87 MGAM (0.50) MGAMGAASIMGAM2CTSK
SCHEMBL233485 0.87 CTSK (0.37) MGAMGAASIMGAM2CTSK
SCHEMBL28314304 0.85 CTSK (0.36) MGAMGAASIMGAM2CTSK
SCHEMBL5534325 0.85 PRKCA (0.46) MGAMGAASIMGAM2CTSK
SCHEMBL10553245 0.83 MAPT (0.48) MAPTMAPK1LMNAALDH1A1MEN1
SCHEMBL6785594 0.83 MEN1 (0.48) CTSKMAPTMAPK1LMNAALDH1A1
SCHEMBL17021237 0.82 CTSK (0.34) MGAMGAASIMGAM2CTSK
SCHEMBL7507859 0.82 MAPT (0.40) MGAMGAASIMGAM2CTSK
SCHEMBL9903061 0.81 MAPT (0.42) CTSKMAPTMAPK1LMNAALDH1A1
SCHEMBL5175527 0.80 CTSK (0.33) CTSKMAPTMAPK1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230223869-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies, Inc. (US) 2023-07-13 — — US claimed
US-11601069-B2 Electrostatic machines that include a malonate in a dielectric fluid C-Motive Technologies, Inc. (US) 2023-03-07 — — US claimed
US-20210391809-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION NATIONAL SCIENCE FOUNDATION 2021-12-16 — — US claimed
US-11114951-B2 Electrostatic machine system and method of operation C-MOTIVE TECHNOLOGIES INC. (US) 2021-09-07 — — US claimed
CN-107922575-B Process for producing rigid polyurethane foams 巴斯夫欧洲公司 2021-08-17 — — CN claimed
US-20190296659-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-MOTIVE TECHNOLOGIES INC. (US) 2019-09-26 — — US claimed
EP-3539208-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies Inc. (US) 2019-09-18 — — EP claimed
EP-0261442-B1 MALONIC ACID DERIVATIVES NIHON NOHYAKU CO., LTD. (JP) 1991-11-13 — — EP claimed
US-12209094-B2 CCR2 receptor antagonists and uses thereof CENTREXION THERAPEUTICS CORPORATION (US) 2025-01-28 — — US disclosed
US-20240109909-A1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF ANKURA TRUST COMPANY, LLC, AS ADMINISTRATIVE AND COLLATERAL AGENT 2024-04-04 — — US disclosed
CN-117178030-A Aqueous coating composition for corrosion protection 湛新奥地利有限公司 2023-12-05 — — CN disclosed
US-11731981-B2 CCR2 receptor antagonists and uses thereof CENTREXION THERAPEUTICS CORPORATION (US) 2023-08-22 — — US disclosed
US-20230223869-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION C-Motive Technologies, Inc. (US) 2023-07-13 — — US disclosed
US-11601069-B2 Electrostatic machines that include a malonate in a dielectric fluid C-Motive Technologies, Inc. (US) 2023-03-07 — — US disclosed
US-4501896-A Phenylmercaptotetrazolo- and nitroindazolo masked development/image modifiers E. I. DU PONT DE NEMOURS AND COMPANY (US) 1985-02-26 — — US disclosed
EP-0094599-A1 Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation MITSUBISHI KASEI CORPORATION (JP) 1983-11-23 — — EP disclosed
EP-0090673-A2 Image-forming elements KONICA CORPORATION (JP) 1983-10-05 — — EP disclosed
EP-0077980-A2 (Potassium ion-selective membrane) electrode NOVA BIOMEDICAL CORPORATION (US) 1983-05-04 — — EP disclosed
US-4361473-A CROWN COMPOUNDS NOVA BIOMEDICAL CORPORATION (US) 1982-11-30 — — US disclosed
US-4343893-A RELEASED VIA ELECTRON TRANSFER E. I. DU PONT DE NEMOURS AND COMPANY (US) 1982-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210391809-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION EZH2, LAGE3, CHD4 MGAM 689/4885GAA 3316/4885SI 3674/4885
US-11114951-B2 Electrostatic machine system and method of operation EZH2, LAGE3, CHD4 MGAM 689/4885GAA 3316/4885SI 3674/4885
US-11731981-B2 CCR2 receptor antagonists and uses thereof CCR2, CCRL2, CCR1 MGAM 3480/4885GAA 4693/4885SI 4617/4885
US-20240109909-A1 CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF CCR2, CCRL2, CCR1 MGAM 3480/4885GAA 4693/4885SI 4617/4885
US-12209094-B2 CCR2 receptor antagonists and uses thereof CCR2, CCRL2, CCR1 MGAM 3480/4885GAA 4693/4885SI 4617/4885
US-20190296659-A1 ELECTROSTATIC MACHINE SYSTEM AND METHOD OF OPERATION EZH2, LAGE3, CHD4 MGAM 689/4885GAA 3316/4885SI 3674/4885
US-11601069-B2 Electrostatic machines that include a malonate in a dielectric fluid MAL2, SELE, LAGE3 MGAM 119/4885GAA 1533/4885SI 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.